Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Royal Diamond Imports, Inc.
WARNING LETTER
•Royal Diamond Imports, Inc.•July 15, 2025

Royal Diamond Imports, Inc. – FDA Warning Letter, Jul 15, 2025

Record Details

**FDA Warning Letter Summary**

**Company:** Roxy Instamix

**Inspection Dates:** Not specified in the document.

**Main Violations/Issues:** 1. **Adulterated Human Foods:** The Roxy Instamix Complex Alkaloid Drink Mix, containing 7-hydroxymitragynine (7-OH) derived from kratom extract, is considered an unsafe food additive. The FDA has not approved kratom extract for use in conventional foods, and it does not meet the Generally Recognized as Safe (GRAS) criteria. The introduction of such adulterated food into interstate commerce is prohibited.

2. **Unapproved New Drugs:** The 7-OH tablets, including ROXY 7-OH and ROXY XL 7-OH, are marketed with claims suggesting they can diagnose, cure, mitigate, treat, or prevent disease, classifying them as drugs under the Federal Food, Drug, and Cosmetic Act. These products have not received FDA approval as drugs, making their marketing illegal.

**Regulatory Framework:** - The Federal Food, Drug, and Cosmetic Act prohibits the introduction of adulterated foods and unapproved new drugs into interstate commerce. - Section 201(s) and 409 of the Act address food additives, requiring FDA approval for safety. - Section 201(g)(1) of the Act defines drugs and requires FDA approval for marketing.

**Required Actions:** - Cease the distribution and sale of the adulterated food products and unapproved new drugs. - Remove any claims from marketing materials that suggest the products have drug-like effects. - Ensure compliance with FDA regulations before reintroducing any products into the market.

The FDA emphasizes the need for immediate corrective actions to avoid further regulatory actions, including potential seizure or injunction.

Company
Royal Diamond Imports, Inc.
Inspection date
July 15, 2025
Product type
Drugs
Office
Human Foods Program
People
  • Ann M. Oxenham (Director)
  • Jill P. Furman (Director)
View Company Profile

ID · 301e4f33-b57c-4654-9864-b24e3ca441c7

Violation Codes9
21 U.S.C. 331(a)21 U.S.C. 321(s)21 U.S.C. 348(a)21 U.S.C. 342(a)(2)(C)(i)21 CFR 170.30(a)-(c)21 U.S.C. 321(g)(1)21 U.S.C. 321(p)21 U.S.C. 331(d)21.U.S.C. 355(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Royal Diamond Imports, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.